PRESS RELEASES

Date	Title
Jan 3, 2017	Ardelyx Announces Presentation at J.P. Morgan 35th Annual Healthcare Conference
Nov 7, 2016	Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress
Oct 31, 2016	Ardelyx to Announce Third Quarter 2016 Financial Results on November 7, 2016
Oct 24, 2016	Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
Oct 19, 2016	Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting
Sep 22, 2016	Ardelyx to Present at Ladenburg Thalmann 2016 Healthcare Conference
Aug 15, 2016	Ardelyx to Present at Wedbush PacGrow Healthcare Conference
Aug 8, 2016	Ardelyx Reports Second Quarter 2016 Financial Results
Aug 1, 2016	Ardelyx to Report Second Quarter 2016 Financial Results on August 8th, 2016
Aug 1, 2016	Ardelyx Receives Notice of Allowance of Composition of Matter Patent Covering its Novel Potassium Binder RDX227675

FAQs

Email Alerts

Connect

Bay Area
34175 Ardenwood Boulevard
Fremont, CA 94555

Boston Area
200 West Street, 4th Floor
Waltham, MA 02451

Phone: 510.745.1700

Inquiries:
General: info@ardelyx.com
Media: media@ardelyx.com
Investor: investor@ardelyx.com
Business Development: partnering@ardelyx.com